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Profiling Motility Signal-Specific Genes in Primary
Human Keratinocytes
Chieh-Fang Cheng1, Jianhua Fan1, Balaji Bandyopahdhay1, Dennis Mock2, Shengxi Guan1, Mei Chen1,
David T. Woodley1,3 and Wei Li1,3
Regulation of human keratinocyte (HK) migration is critical for skin wound healing. Profiling HK migration-
specific genes could help us gain a comprehensive understanding of the process. The main challenge is to
separate genes that are unrelated to migration, but simultaneously induced by the same growth factor. In this
study, we took advantage of a unique response of HKs to transforming growth factor-b (TGF-b), which inhibits
proliferation but not migration of HKs, to suppress selectively the proliferation-related genes. Furthermore we
stimulated HKs independently with TGF-a or insulin and identified the common genes and eliminated TGF-a- or
insulin-specific genes. Under these conditions, we obtained profiles of the immediate-early genes (IEGs, at
30minutes), early genes (EGs, at 60minutes), and delayed-early genes (DEGs, at 120minutes) by microarray
analyses, followed by quantitative real-time reverse transcription–PCR (QRT-PCR) validation and functional
characterization by RNA interference (RNAi). Our results revealed the following: (1) 25 upregulated and 1
downregulated IEGs; (2) 58 upregulated and 15 downregulated EGs, and (3) 13 upregulated and 3 downregulated
DEGs in both TGF-a- and insulin-stimulated HKs. Three genes, all encoding secreted molecules, were
investigated in HK migration. These cell motility-specific gene profiles may prove useful to skin wound healing.
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INTRODUCTION
Cell migration is the result of repeated cycles of cytoskeleton-
mediated protrusion and polarization, formation of adhesive
contacts, cell contraction, and retraction at the trailing edge
(Lauffenburger and Horwitz, 1996). These sequential events
are initiated and continuously driven by two extracellular
environmental cues, extracellular matrices (ECMs) and
soluble growth factors (GFs) (Eliceiri, 2001; Schwartz and
Ginsberg, 2002). In response to a motility signal, a cell on an
ECM substratum begins to show an initial protrusion of the
plasma membrane at the cell’s leading edge by polymerizing
actin filaments into a membrane structure called lamellipo-
dia. Adhesive complexes, which are composed of clusters of
integrin receptors, actin filaments, and associated proteins at
the plasma membrane, are then established. As the cell migrates,
the adhesive complexes at the leading edge of the cell develop
into larger, more organized complexes, called focal adhesions
(Gumbiner, 1996). The focal adhesions then serve as points of
traction over which the body of the cell translocates toward the
leading edge. Subsequent release from the ECM substratum at
the rear of the cell allows the cell body to be displaced and
consequently achieve a net step in the forward direction
(Mitchison and Cramer, 1996). Between the two distinct
migration cues, that is, ECMs versus GFs, Li et al. showed that
ECMs, but not GFs, initiate cell migration. In contrast, GFs
optimize the ECM-initiated cell migration and provide moving
directionality (Li et al., 2004b, c). These studies suggest
that haptotaxis (ECM-driven) is a prerequisite for chemotaxis
(GF-induced). Haptotaxis can occur without chemotaxis, as
previously reported (Carter, 1967). However, the reverse is not
true. Chemotaxis cannot take place in the absence of ECM.
This regulation of cell migration is extremely important in
the process of healing a human skin wound, since epidermal
and dermal, as well as non-resident bone marrow-derived,
cells must all migrate over or into the wound bed. In
unwounded skin, the resident skin cells are nourished by a
filtrate of plasma from dermal blood vessels. When skin is
wounded, the resident cells in the wound encounter an acute
environmental transition from plasma to serum for the first time.
Then, as the wound heals, wound remodeling initiates new
blood vessel formation and a subsequent transition from serum
back to plasma. Interestingly, the ‘‘plasma-to-serum-to-plasma’’
transition coincides with the three classical phases of
skin wound healing as previously described (Singer and
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Clark, 1999). We reported previously that human serum, but
not human plasma, promotes keratinocyte migration (Henry
et al., 2003).
Re-epithelialization, the process by which human kerati-
nocytes (HKs) migrate over the wound bed and resurface the
wound, is a central event that resolves problems associated
with skin wounds, that is, infection, water loss, metabolic
disturbance, nutritional loss, and pain. Re-epithelialization
largely depends upon the migration of HKs across a wound
bed, in which the microenvironment (GFs and connective
tissue components) is very different from that experienced by
the same HKs in unwounded skin (Odland and Ross, 1968;
Woodley et al., 1993). The physiological factors that induce
HKs to migrate from the wound margins are not fully defined.
However, we compared all reported HK pro-motility factors
and demonstrated that transforming growth factor-a (TGF-a)
and insulin are the most potent ‘‘motogens’’ in human serum
that enhance ECM-initiated HK migration (Li et al., 2006). HK
migration occurs long before cell division, which occurs only
after a 36–48 hour lag phase (Li et al., 2004c). Within the
wound bed, fibronectin and collagen are two ECM compo-
nents capable of initiating HK migration. Odland and Ross
(1968) demonstrated by electron microscopy that dramatic
morphological changes occur when HKs transform from a
stationary mode to a migratory mode. Stationary cells are
polar and cuboidal and exhibit desmosomal and hemidesmo-
somal connections. When the same cells are in a migratory
mode, they flatten out, extend lamellipodia with a ruffled
plasma membrane, dramatically decrease surface desmo-
somes and hemidesmosomes, retract their tonofilaments to a
perinuclear location, increase surface gap junctions, and
dramatically assemble actin cables that form belt-like
structures related to the inner aspects of the plasma
membrane (Woodley et al., 1986).
GFs stimulate cell migration by signal transduction from
their cell-surface receptors to cytoplasmic signaling networks
and then to gene expression in the nucleus. Products of the
newly expressed genes in turn act either intracellularly or
extracellularly to execute the motility signal initiated at the cell
surface, resulting in cell migration. While a great many
previous studies focused on individual signaling pathways or
genes involved in the control of cell migration, there have
been few studies that have systematically analyzed the gene
profiles of cell motility-specific signals. A major reason was the
technical problems of sorting out the inseparable pleiotropic
effects of a given GF, such as mitogenic, motogenic, and
factor-specific effects. Therefore, genes previously reported in
GF-treated cells were actually a mixture of genes induced by
multiple distinct signals from the same GF. In this study, we
have designed and used a unique approach to separate
migration signal-regulated genes from genes unrelated to
migration and yet induced by the same GF.
RESULTS
Strategy No. 1 for identification of HK motility-specific gene
expression: dual pro-motility GF stimulation
A major challenge in identifying a cell migration-specific gene
profile is to separate migration signal-regulated genes from
genes that are migration-unrelated, but often coexpressed in
response to the same GF stimulation, such as proliferation-
related genes or genes involved in factor-specific responses
(such as glucose-uptake genes specifically induced by insulin
and not by other GFs). We have previously shown that
migration of primary human HKs could be equally stimulated
by more than one GF, specifically TGF-a and insulin (Li et al.,
2006). This property would allow us to select for the genes
commonly regulated by both GFs and, at the same time, to
eliminate factor-specific genes. Therefore, we selected TGF-a
and insulin as two parallel migration-promoting cues to
independently induce gene expression in HKs.
We first wanted to determine what time points of the GF
stimulation should be used and why. The time course of TGF-
a and insulin-stimulated HK migration, as shown in Figure
1a, revealed that, for the initial 60minutes following
stimulation, there was little detectable enhancement of HK
migration in response to either TGF-a (diamond-filled bars) or
insulin (solid black bars) over collagen control (open bars). A
significant stimulation of HK migration became evident
120minutes after TGF-a or insulin stimulation (bars 11 and
12 vs 10). These observations suggested that, following
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Figure 1. TGF-a and insulin-stimulated keratinocyte migration on type I
collagen. HKs were serum-starved overnight and subjected to colloidal gold
migration assays in the presence or absence of TGF-a and insulin. Only
migration index (MI) is presented, as previously described (Li et al., 2004a).
MI is defined as the percentage of the track area compared with the total
area under the microscope and is quantified by computer-assisted analyses.
(a) The migration of keratinocytes was time-dependent in response to
TGF-a or insulin. HKs showed significant migration after 2 hours of GF
stimulation. This experiment was repeated more than three times.
(b) Cycloheximide was added at the indicated concentrations to the cells
30minutes prior to GF stimulation. Presence of cycloheximide inhibited
HK migration stimulated by TGF-a or insulin in a dose-dependent manner,
in comparison with control (lanes 1, 2, 6) (*Po0.001). The experiment
was repeated twice.
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addition of a GF, quiescent HKs need at least 60minutes of
‘‘cellular preparation’’ prior to exhibiting induced migration.
To test if de novo protein synthesis is required, we treated
HKs with increasing concentrations of the protein synthesis
inhibitor cycloheximide and subjected the cells to migration
assays in response to TGF-a or insulin. As shown in Figure 1b,
cycloheximide inhibited both TGF-a-stimulated (bars 3–5)
and insulin-stimulated (bars 7–9) HK migration in a dose-
dependent manner. The inhibitory effects were not due to
cellular cytotoxicity, because more than 94% of the cells
survived in fresh medium after removal of cycloheximide.
We decided to focus on the gene expression profiles
following 30minutes (to detect immediately-early genes, or
IEGs), 60minutes (early genes, or EGs), and 120minutes
(delayed-early genes, or DEGs) stimulation of HKs by TGF-a
and insulin. GF-induced IEGs, EGs, and DEGs have
previously been well defined by Stiles and Herschman
(Rollins and Stiles, 1989; Herschman, 1991).
Strategy No. 2 for identification of migration-specific gene
expression: using TGF-b to suppress proliferation signal-induced
genes
As mentioned previously, many GFs stimulate both prolifera-
tion and migration in HKs, like TGF-a and insulin. To
separate these two major signaling events and focus on the
migration-specific genes, we took advantage of our previous
observation that TGF-b inhibits serum-stimulated HK prolifera-
tion but not migration (Sarret et al., 1992; Bandyopadhyay et al.,
2006). To verify if this is also true for TGF-a- and insulin-
stimulated proliferation versus migration in HKs, we carried out
HK migration and proliferation assays in the presence or
absence of TGF-b. In the same experiments, human dermal
fibroblasts were included as control. As shown in Figure 2,
TGF-b inhibited the proliferation of both TGF-a-stimulated HKs
(Figure 2a) and platelet-derived growth factor-BB-stimulated
human dermal fibroblasts (Figure 2b) in a dose-dependent
manner. As shown previously (Bandyopadhyay et al., 2006),
TGF-b also inhibited platelet-derived growth factor-BB-stimu-
lated human dermal fibroblast migration (Figure 2c). However,
TGF-b was unable to block TGF-a-stimulated HK migration
(Figure 2d). Similar results were obtained for insulin-stimulated
HKmigration (data not shown). Thus, in HKs, TGF-a and insulin
signaling to promote proliferation and migration can be
separated by the presence of TGF-b. This unique property of
HKs became extremely useful for our purpose of identifying the
migration-specific gene profiles in the cells.
Final design of approach
On the basis of (i) dual GF stimulation and (ii) selective
inhibition of HK proliferation by TGF-b, the entire design of
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Figure 2. TGF-b blocked GF-stimulated HK proliferation, but not migration. Colloidal gold migration assay and DNA synthesis assay were carried out
as described previously by us (Bandyopadhyay et al., 2006). (a–d) TGF-b blocked GF-induced proliferation of HKs and dermal fibroblasts (DFs) in a
dose-dependent manner (a and b). However, TGF-b selectively blocked GF-induced migration of DFs and not HKs (c and d). The experiments were
repeated more than three times.
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our approach is schematically shown in Figure 3. Therefore,
we carried out the following sequential experimental
procedures, aiming to identify migration-specific gene
profiles: (1) HKs were to be pretreated with TGF-b to block
cell proliferation and, therefore, the expression of key
growth-related genes; (2) the cells, then, were to be
stimulated with TGF-a or insulin for 30, 60, and 120minutes;
(3) total RNA was to be isolated from the cells and subjected
to DNA microarray analyses; (4) commonly regulated genes
and factor-specific genes in response to both TGF-a and
insulin were to be identified. Steps 1–4 were to be repeated
using fresh cell cultures, prior to step 5: (5) 12 genes were to
be randomly selected and subjected to quantitative real-time
reverse transcription–PCR (QRT–PCR) verification.
To investigate whether the early signaling pathways (that
is, prior to transcription activation) of TGF-a and insulin are
affected by the co-presence of TGF-b, the lysates of cells that
were serum-starved and GF-stimulated in the absence or
presence of TGF-b were subjected to immunoblotting
analyses with anti-phosphotyrosine, anti-phospho-Smad, or
a loading control antibody. As shown in Figure 4, TGF-a
stimulation for 30, 60, and 120minutes caused increased
tyrosine phosphorylation of several previously known protein
species, including the 170-kDa epidermal growth factor
receptor, the 140-kDa phospholipase-C-g, the 62-kDa Dok,
and the 42/44-kDa ERK1/2 (Figure 4a, lanes 2–4 vs lane 1).
Weak detection of the epidermal growth factor receptor
tyrosine phosphorylation was expected because it peaks
around 5minutes after TGF-a stimulation and then declines
(data not shown). In addition, we used a physiological
concentration of 20 ngml1 of TGF-a (in contrast to the
200–500ngml1 frequently used for short periods of stimula-
tion; see Li et al., 2006 and references therein). Co-presence
of TGF-b did not affect the pattern or intensity of the
phosphotyrosine proteins (Figure 4a, lanes 6–8 vs lane 5).
Similarly, 5 mgml1 insulin stimulation caused increased
phosphorylation of the well-characterized 70-kDa b subunit
of the insulin receptor (Figure 4b, lanes 2–4 vs lane 1). As
expected, co-presence of TGF-b did not interfere with the
insulin-stimulated receptor activation (Figure 4b, lanes 6–8 vs
lane 5). These data suggest that TGF-b’s blocking point is
likely at downstream transcription control levels. For
example, it has previously been shown that TGF-b blocks
the expression of the IEG c-myc (Pietenpol et al., 1990). To
make sure that TGF-b signaling remains active during the
entire 120-minute period of GF stimulation, we tested the
activation of Smad2/3, a downstream signaling molecule for
TGF-b. As shown, TGF-b-induced phosphorylation of Smad2/
3 remained detectable for the entire 2 hours in both TGF-a-
stimulated (Figure 4c, lanes 5–8) and insulin-stimulated
(Figure 4e, lanes 5–8) cells. In contrast, neither TGF-a nor
insulin stimulation alone caused any detectable phosphor-
ylation of Smad2/3 (Figure 4c and d, lanes 1–4). Anti-p38
blotting of the same membrane was used as an equal sample
loading control (Figure 4d and f).
To estimate how many TGF-a-regulated genes were
blocked in TGF-b-pretreated HKs, HKs were pretreated with
or without TGF-b prior to TGF-a stimulation, which promotes
both migration and proliferation. Total RNA isolated from the
cells was analyzed by DNA microarray analysis. We found
Migration-specific gene profiles
Strategy #2:
(TGFβ blockade of GS genes)
Strategy #1:
(selecting common genes)
Mixed gene profiles: FS GS MS FS GS MS
InsulinTGFα
In human keratinocytes
MS, motility-specificGS, growth-specificFS, factor-specific,
Figure 3. A schematic representation of the overall design of approach.
TGF-a and insulin are two potent stimulators of human keratinocyte
migration. Therefore, dual stimulation with both GFs was used to eliminate
the factor-specific (FS) genes, such as insulin-specific genes involved in
glucose uptake. TGF-b selectively inhibits TGF-a- or insulin-stimulated
proliferation, and not migration, of human keratinocytes, preventing
growth-specific (GS) gene expression. After two layers of ‘‘gene filtration’’,
motility-specific (MS) gene profiles are anticipated.
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Figure 4. TGF-b did not affect the early signaling by TGF-a or insulin. (a and b)
Serum-starved HKs were unstimulated or stimulated with TGF-a
(20ngml1) or insulin (5mgml1) in the absence or presence of TGF-b. Total
lysates of the cells were subjected to immunoblotting with anti-phosphotyrosine
antibodies. TGF-a or insulin stimulated tyrosine phosphorylation of the
previously reported proteins (lanes 1–4). None of the phosphotyrosine proteins
were affected by the presence of TGF-b (lanes 5–8). The effectiveness of TGF-b
presence was indicated by increased Smad phosphorylation in both TGF-a- (c
and d) and insulin- (e and f) treated cells. The experiments were repeated three
times.
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that TGF-b pretreatment blocked 124 of the total 500
TGF-a-regulated (up- and downregulated) genes at the
60-minute time point (data not shown). These data indicate
that the approach of using TGF-b to block cell-proliferation-
related gene expression is feasible.
Commonly up- and downregulated IEG, EG, and DEG profiles in
migrating, but not proliferating, HKs
We used SScore to compare the expression levels of each
gene before and after GF stimulation at each of the three time
points. SScore determines the significance of the relative
expression level by probe-to-probe comparison (Kennedy
et al., 2006). The results are shown in Table 1. At 30-minute
stimulation (to detect IEGs), TGF-a upregulated a total of 71
genes and downregulated a total of 46 genes. At the same
time point, insulin upregulated 75 genes and downregulated
28 genes. Among them, 25 upregulated genes and one
downregulated gene were detected in both TGF-a- and
insulin-stimulated cells. Therefore, among the IEGs, approxi-
mately 35% of the genes upregulated and 2% of the genes
downregulated by TGF-a were shared by insulin stimulation,
whereas 33% of the genes upregulated and 4% of the genes
downregulated by insulin were shared by TGF-a stimulation.
At 60-minute stimulation (to detect EGs), TGF-a caused
upregulation of 174 genes and downregulation of 41 genes.
Insulin caused upregulation of 109 genes and downregula-
tion of 47 genes. Among them, 58 upregulated and 15
downregulated genes were detected in both TGF-a- and
insulin-stimulated cells. Among the EGs, 33% of the genes
upregulated and 37% of the genes downregulated by TGF-a
were shared by insulin stimulation, whereas 53% of the genes
upregulated and 32% of the genes downregulated by insulin
were shared by TGF-a stimulation.
At 120-minute stimulation, TGF-a upregulated 209 genes
and downregulated 74 genes. Insulin upregulated 42 genes
and downregulated 39 genes. Among them, 13 upregulated
and 3 downregulated genes were detected in both TGF-a-
and insulin-stimulated cells. Among these DEGs, 6% of the
genes upregulated and 4% of the genes downregulated by
TGF-a were shared by insulin, whereas 31% of the genes
upregulated and 8% of the genes downregulated by insulin
were shared by TGF-a stimulation. The genes that were
significantly regulated (Po0.05) by both TGF-a and insulin
are presented in Figure 5. As shown, we classified the
identified genes into five different categories on the basis of
the cellular location of the genes’ products. The five
categories are the following: extracellular factors, cell-surface
molecules, cytosolic molecules, nuclear molecules, and less-
well-characterized proteins. We generated a dendrogram for
the genes in each category and, therefore, created a total of
five dendrograms. These analyses revealed the kinetics of the
gene expression and a comparison of their expression
patterns. The upregulated genes are shown in red, and the
downregulated genes are shown in green. The unchanged
genes are shown in black. The degree of the change is shown
by an increasing intensity of the color, as indicated by the
scale bar.
To understand the expression profiles, we analyzed IEGs,
EGs, and DEGs according to the cellular locations and
functions of their encoded gene products (Table S1). Among
the IEGs upregulated, 10 genes were extracellular factors
(40%), one gene was a cell-surface protein (4%), five genes
were cytosolic molecules (20%), eight genes were nuclear
molecules (32%), and one was less characterized (4%). Only
one IEG, a nuclear protein, was downregulated.
Among the EGs upregulated, 13 were secreted extracel-
lular factors (23%), eight were cell-surface molecules (14%),
21 were cytosolic molecules (36%), 6 were nuclear
molecules (10%), and 10 were less characterized (17%).
Among the EGs downregulated, 2 were cell-surface mole-
cules (13%), 4 were cytosolic molecules (27%), and 9 were
nuclear molecules (60%). For the DEGs up-regulated, 7 were
extracellular factors (54%), 5 were cytosolic molecules
(38%), and 1 was a nuclear molecule (8%). For the DEGs
downregulated, 1 was a cell-surface molecule (33%), 1 was a
cytosolic molecule (33%), and 1 was a nuclear molecule
(33%).
Verification of DNA microarray data by QRT–PCR
To verify the gene profiles of the microarray analyses, we
randomly selected 12 genes that were either up- or down-
regulated at at least one of the three stimulation time points
by both TGF-a and insulin. Expression of these genes in the
original total RNA samples was analyzed by QRT–PCR
analyses. A total of 34 reactions for both TGF-a (17 reactions)
and insulin (17 reactions) were carried out. The DNA
sequences of the 12 pairs of real time PCR primers plus a
pair of glyceraldehyde-3-phosphate dehydrogenase primers
are shown in Table S2. As shown in Table S3, data from the
QRT–PCR analyses on all the genes selected were qualita-
tively consistent with those of DNA microarray analyses.
Quantitatively, however, among the 34 reactions, 28
(82%) exhibited greater-fold changes by QRT–PCR than by
Table 1. TGF-a- and insulin-regulated total and
common genes
Upregulated genes Downregulated genes
Growth
factor 30min 60min 120min 30min 60min 120min
TGF-a 71 174 209 46 41 74
Insulin 75 109 42 28 47 39
Shared
genes
25 58 13 1 15 3
% 35 (TGF-a)
33 (ins.)
33 (TGF-a)
53 (ins.)
6 (TGF-a)
31 (ins.)
2 (TGF-a)
4 (ins.)
37 (TGF-a)
32 (ins.)
4 (TGF-a)
8 (ins.)
ins., insulin; TGF, transforming growth factor.
The result of DNA microarray analysis is shown, on the basis of the
significance of gene expression (Po0.05) in the probe-based analysis
calculated by using SScore software. The numbers shown from TGF-a- or
insulin-stimulated cells for the indicated times are the total numbers of
up- or downregulated genes. Among them, the commonly up- or
downregulated genes are referred to as ‘‘shared genes’’. The percentage
of shared genes over the total number of genes regulated under TGF-a or
insulin treatment is shown as ‘‘%’’.
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microarray analyses. The remaining six reactions
showed less-fold changes between QRT–PCR and microarray
analyses.
Functional characterization of three secreted gene products
Finally, to investigate whether the ‘‘migration signal-regu-
lated’’ genes indeed play a role in HK migration, we selected
three genes that all encode secreted polypeptides: heparin-
binding EGF-like GF (HB-EGF), stromelysin-2 (matrix metal-
loproteinase-10 (MMP-10)), and chemokine (CXC family)
ligand 3 (CXCL3). Both HB-EGF and MMP-10 have
previously been reported to promote HK migration and
wound healing (Hashimoto et al., 1994; Krampert et al.,
2004; Shirakata et al., 2005). While little is known about the
role of CXCL3 in HK migration, mice that are deficient in
CXCR2, a receptor for CXC family ligands, show delayed
wound healing (Devalaraja et al., 2000). We designed small
hairpin RNAs against each of the three genes and cloned
them into the lentiviral small interfering RNA delivery system,
FG12 (see Materials and Methods). As previously demon-
strated by us, the FG12 system offers more than 95% RNA
interference (RNAi) transduction efficiency and permanent
gene knockdown in HKs (Bandyopadhyay et al., 2006; Fan
et al., 2006).
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Figure 5. The DNA microarray gene profile. The relative expression levels of the genes in HKs in response to TGF-a or insulin stimulation for 30, 60,
and 120minutes are shown by dendrograms. Only those genes that were significantly regulated by both TGF-a and insulin for at least one time point are
shown. These genes were classified as follows into different categories on the basis of the locations of their protein products: extracellular factors (a), surface
molecules (b), cytosolic molecules (c), nuclear molecules (d), and less characterized molecules (e). The genes that were upregulated at certain time points
are shown in red, and those downregulated at certain time points are shown in green. Genes with similar kinetic expression patterns in response to both
TGF-a and insulin were clustered together. Similarities of the expression patterns are indicated by the hierarchy lines on the left-hand side. For certain
genes, there were more than one probe set that detected the expression of the genes. The probe sets, which detected a significant difference in response to
the GF stimulation for at least one time point, are presented here. The final presented data resulted from the consensus of DNA array analysis of mRNA
samples from two independent cultures for each time point.
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To verify the effectiveness of the RNAi constructs, total
RNA was extracted from the cells and subjected to QRT–PCR
analyses. As shown in Figure 6a, in siRNA against heparin
binding EGF-like growth factor (siHB-EGF)-infected HKs, the
HB-EGF mRNA level was reduced by 83% (bar 2) in
comparison with that in HKs infected with control siLac Z
(bar 1). Similarly, the mRNA levels of CXCL3 and siMMP-10
were reduced by more than 60–70% (bars 3 and 4). At the
protein level, cell lysate or conditioned medium was
collected from the gene knockdown or control (vector alone
or siLacZ) cells and subjected to immunoblotting assays with
antibodies against each of the three gene products. Con-
sistently, the level of HB-EGF protein was reduced more than
95% (Figure 6b, lane 3 vs lanes 1 and 2). Anti-p38 antibody
immunoblots were used as sample loading controls. The
protein level of CXCL3 in the cells was reduced by more than
70% in comparison with that in HKs infected with empty
vector or siLacZ (Figure 6d, lane 3 vs lanes 1 and 2).
Since we were unable to detect the intracellular protein
level of MMP-10 in HKs, we collected TGF-a-stimulated
conditioned media of HKs infected with either control
constructs or siMMP-10 and subjected them to immunoblot-
ting analysis with anti-MMP-10 antibodies. We detected a
significant amount of secreted MMP-10 from conditioned
media of the control cells (Figure 6f, lanes 1 and 2). However,
MMP-10 knockdown almost completely blocked MMP-10
secretion (Figure 5f, lane 3 vs lanes 1 and 2). Therefore, our
RNAi approach effectively downregulated the genes of
interest. As mentioned previously, this downregulation was
permanent throughout the life span of the cells in culture.
The above gene-knockdown HKs were then subjected to
cell migration assays in response to TGF-a and insulin. As
expected, both TGF-a and insulin strongly stimulated the
migration of HKs infected with empty vector lentivirus (Figure
6g, bars 2 and 3 vs bars 1). However, the GF-induced
migration of siCXCL3-lentiviral-infected HKs was decreased
by 40–50% in comparison to the control HKs (bars 5, 6 vs bar
2, 3). These data were quantitatively consistent with the
immunoblotting results in which the cellular protein level of
CXCL3 was downregulated approximately 70% by siCXCL3
(see Figure 6c). Therefore, CXCL3 is required for HK
migration in response to the GFs. Surprisingly, the GF-
stimulated HK migration was not affected by HB-EGF
knockdown (bars 11 and 12). On the other hand, MMP-10
knockdown only slightly, but significantly, lowered TGF-a-
stimulated HK migration (bar 8 vs bar 2), but did not affect
insulin-induced HK migration (bar 9 vs bar 3). These results
suggest that MMP-10 and HB-EGF, although secreted by HKs,
are not essential for HK migration. We postulate that when
HK-derived MMP-10 and HB-EGF are secreted into the
wound environment, they in turn influence migration of other
skin cell types such as dermal fibroblasts and dermal
microvascular endothelial cells, whose migration is equally
critical for wound healing and remodeling.
DISCUSSION
Cell migration and cell proliferation are two mutually
exclusive events. Migrating cells are not proliferating and,
similarly, proliferating cells are not simultaneously migrating.
In cell migration assays, mitomycin C is often used to
eliminate the potential contribution of cell proliferation to the
results of these assays and, therefore, it might be a useful
alternative to block proliferation-related gene expression.
However, since the blocking point of mitomycin C
in proliferating cells lies in the very downstream G2/M
transition phase of the cell cycle, it will not block the growth
signal-induced EG expression. Therefore, mitomycin C does
not help to identify migration signal-specific genes. The
central idea of this study is to make use of the fact that TGF-b
blocks HK proliferation but not migration (Sarret et al., 1992;
Bandyopadhyay et al., 2006). In addition, however, TGF-b is
known to block the expression of both IEGs, such as c-myc
(Pietenpol et al., 1990), and Rb-regulated DEGs (Koike et al.,
1994). Furthermore, to further ensure the ‘‘purity’’ of the
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Figure 6. Functional characterization of three secreted gene products
in HK migration. HKs, infected with FG12 system carrying vector alone,
control siLac-Z, or small interfering RNA against each of the three
candidate genes, were subjected to RT–PCR, immunoblotting, and colloidal
gold migration assays. (a) Total RNA from these cells was isolated 5 days
following infection and was subjected to RT–PCR. (b–f) To detect the protein
expression levels, lysates of the HKs, starved in serum-free medium overnight,
were extracted and immunoblotted with antibodies against HB-EGF or
CXCL3. To detect secreted MMP-10 proteins, infected HKs were starved in
serum-free medium overnight. Conditioned medium (CM) was collected
and concentrated 100 times. The CM was analyzed by western blot with an
anti-MMP-10 antibody (f). (g) After the effectiveness of the RNAi was
confirmed, colloidal gold migration assay was carried out to functionally
characterize the importance of these genes in HK migration. The experiments
were repeated three times (*Po0.05).
www.jidonline.org 1987
C-F Cheng et al.
Keratinocyte Motility-Specific Gene Profiles
migration-related gene profiles, we stimulated HKs with two
distinct pro-motility factors. We have shown that TGF-a and
insulin are the main keratinocyte pro-motility factors in
human serum (Li et al., 2006).
It is well established that TGF-b’s effects can be divided
into primary and secondary effects. Its primary effects on
most cell types include antiproliferation and/or antimotility.
Its secondary and main effect is to induce expression of many
genes, including ECMs and mitogenic/motogenic GFs,
cytokines, and MMPs. These newly produced factors could
in turn act in either an autocrine or a paracrine manner to
affect various responses of the cells. Our migration assays,
colloidal gold and ‘‘scratch’’ assays, last for 12–16 hours.
Within this period, the physiological concentrations of TGF-b
did not cause any significant change in human keratinocyte
migration stimulated by TGF-a, as we and others have
previously reported, (Sarret et al., 1992; Tsuboi et al., 1992;
Garlick and Taichman 1994; Ashcroft et al., 1999). However,
as mentioned earlier, the ECM and GFs produced by the cells
in response to TGF-b may later act to stimulate cell migration
(for example, 448 hours) (Hebda 1988; Nickoloff et al.,
1988).
Microarray analysis allows profiling large-scale and
comparative gene expression under two different conditions.
Therefore, this approach can provide a useful global picture
of the gene expression involved in a given activity that takes
place inside the cells. In conjunction with the available
knowledge on the kinetics and functions of a given gene, the
technique is helpful to reveal intracellular signaling networks
that execute a specific cellular response such as motility.
Here, we have identified 82 genes commonly upregulated
and 19 genes commonly downregulated by both TGF-a and
insulin following stimulation for up to 2 hours. Among them,
31 of the upregulated genes (38%) have previously been
reported to play a role in cell migration, and 9 of the
downregulated genes (47%) were reported for cell migration.
Among the 14,500 well-characterized genes in the Affymetrix
HU-133A 2.0 array, there are only 187 probes representing
72 genes (0.5%) that are known to relate to cell migration.
Therefore, our strategy ‘‘enriched’’ the pool of migration
signal-specific genes more than 80-fold. In analyzing the
DNA microarray data, we used the SScore program to select
genes significantly regulated by both TGF-a and insulin and
generated dendrograms based on this selection. In the
dendrograms, genes with more than one probe on the
microarray chip were shown more than once, such as
HB-EGF and PHLDA1. These different probe sets for the
same genes tend to cluster together, indicating that their
expression patterns are similar. Results of this analysis further
confirmed the induction or repression of the genes by TGF-a
and insulin, since multiple probe sets for the same genes
showed similar expression patterns.
Our study focused on the migration-specific gene profiles
in primary human keratinocytes in vitro. Are these profiles
relevant to those in HKs in vivo? Unfortunately, this kind of
study using human skin wounds is technically impossible. It
is not possible to wound human skin, take biopsies at
different time points, isolate the RNA from them, and obtain
gene expression profiles. Even in mice, it is not feasible to
isolate the wound cells/tissues without contaminating the
specimens with unwounded tissue. Since the latter is not in
the environment of the wound, the gene expression profiles
from unwounded tissue do not reflect wound healing.
Furthermore, gene profiles from mouse tissue may not be at
all relevant to the gene profiles of human skin wounds.
Second, in a real skin wound, the environment is a mixture of
multiple factors (cytokines, GFs, ECMs, MMPs, and so on). It
is not possible to distinguish what genes are inflammation-
related, proliferation-related, migration-related, differentia-
tion-related, metabolism-related, and so on. It is impossible
to know which gene is induced by what factor.
While microarray has been widely used to determine gene
expression patterns under various environmental and cellular
conditions, to our knowledge this is the first report of gene
expression profiles designed in response to a specific type of
cell-surface signal. Several previous studies also used a DNA
microarray approach to identify gene profiles associated with
wound healing. Fitsialos et al. surveyed the gene expression
profiles during the course of an in vitro scratch assay using
cultured HKs. They used inhibitors of extracellular signal-
regulated kinase, p38-mitogen-activated protein kinase, and
phosphatidylinositol 3-kinase to narrow down the pathway-
specific gene expression profiles (Fitsialos et al., 2007). They
identified several extracellular factors that were induced at
early time points (1–3 hours), such as HB-EGF, vascular
endothelial growth factor, epiregulin (EREG), LIF, SERPINE-1,
and IL-8, and transcription factors, such as Fos, Jun, and
EGR1. These results are consistent with our observations. Roy
et al. (2007) compared the gene expression profiles in
wound-derived blood vessels and blood vessels from intact
human skin. They demonstrated that the extracellular
proteinase MMP-1 was upregulated, which was also ob-
served in our study. In conclusion, our study has provided
comprehensive profiles of the EG expression induced by HK
pro-motility signals. These profiles may serve as a foundation
to gain new insights into the mechanism of the re-
epithelialization process during wound healing.
MATERIALS AND METHODS
Primary HKs were purchased from Cascade Biologics (Portland, OR)
and cultured in Epilife supplemented with human keratinocyte
growth supplements, according to the manufacturer’s instruction.
HKs at passages 4–5 were used in all experiments. Native rat-tail type
I collagen was from BD Biosciences (Bedford, MA). Recombinant
human TGF-a was from R&D Systems, Inc. (Minneapolis, MN).
Recombinant human insulin was from Gibco (Grand Island, NY).
The Human Genome U133A 2.0 GeneChip Array was obtained from
Affymetrix (Santa Clara, CA). Colloidal gold (gold chloride, G4022)
was from Sigma (St Louis, MO). The anti-phospho-Smad2/3 antibody
was from Cell Signaling (Danvers, MA). The anti-human MMP10
antibody was from Chemicon (Temecula, CA). The anti-human HB-
EGF antibody was from R&D Systems. The anti-human CXCL3
antibody was from Aviva Systems Biology (San Diego, CA).
Restriction enzymes and T4 DNA ligase were from New England
BioLabs (Beverly, MA). Plasmid Midi kit was from Promega
(Madison, WI). XL-10 Gold Ultra competent cells (XL-10 Gold)
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were from Stratagene (Kingsport, TN). All other reagents and
supplies, unless indicated, were from VWR (Bristol, CT) or Sigma.
Treatment of HKs with stimulators and inhibitors
HKs were seeded on collagen I-precoated tissue culture plates
(150mm) at around 45% confluence (B2.5 106 cells) in complete
medium and incubated overnight. The next day, the cells
(B4.5 106 cells) were deprived of GFs and incubated in serum-
free medium for 16 hours to arrest the cells at G0/G1 phase. The cells
were then washed with pre-warmed serum-free medium and
incubated in fresh serum-free medium containing 20 ngml1 TGF-
b for 20minutes at 37 1C to block the expression of growth signal-
related genes. TGF-a or insulin was added (in the continued
presence of TGF-b) for 30, 60, and 120minutes. At the end of each
stimulation time point, the cells were washed with ice-cold
phosphate-buffered saline to halt the stimulation and subjected to
RNA isolation, as described below. Duplicate plates (100mm) under
the same conditions were subjected to immunoblotting analyses
for phosphotyrosine and phospho-Smad proteins.
RNA extraction and microarray
Total RNA was extracted from HKs using the RNeasy mini kit
(Qiagen) following the manufacturer’s user manual. After the RNA’s
quality was confirmed by the 260/280 nm ratio of spectrometer
readings and by RNA electrophoresis, the RNA was used for
microarray processing on a Human Genome U133A 2.0 Array
containing 22,000 oligonucleotide probe sets. This array represents
18,400 transcripts and variants, including 14,500 well-characterized
human genes. Briefly, RNA was hybridized with a T7-(dT) promoter
and reverse-transcribed to cDNA using Superscript II reverse
transcriptase (200U ml1). Second-strand cDNA was synthesized
by DNA polymerase I. For in vitro reverse transcription, T7 RNA
polymerase and biotin-labeled ribonucleotides were also added.
The synthesized biotin-labeled cRNA was fragmented and then
hybridized to probe the array at 45 1C for 16 hours. The data were
analyzed using DCHIP software (Li and Hung Wong, 2001). The
signal for each probe was verified by the PM/MM ratio and reported
as present, marginal, or absent. One-to-one comparisons were
performed with samples from control versus growth-factor-treated
cells. The data were discarded if signals were absent from both the
groups. The comparison of the expression level of each gene
between GF treatment and control was analyzed by SScore, a
program from Bioconductor (Kennedy et al., 2006), and genes with
Po0.05 were selected. The expression patterns of selected genes
were summarized by hierarchical clustering analysis (Eisen et al.,
1998). The entire DNA array experiment was repeated from cell
culture to data analyses and the data of consensus among the
experiments are presented.
QRT-PCR
Extracted total RNA was first subjected to reverse-transcription
assays using TaqMan Reverse Transcription Reagents with oligo
d(T)16 as the primer. The detailed procedure was as described in the
user manual (Applied Biosystems, Branchburg, NJ). Real-time PCR
was performed using SYBR Green PCR Master Mix. The reactions
were performed in 384-well clear optical reaction plates in the
7900HT system and exported by the SDS 2.1 program. All the
instruments and reagents related to reverse-transcription reaction
and real-time PCR were from Applied Biosystems. Primers for real-
time PCR were designed using the on-line program PrimerQuest
from Integrated DNA Technology Inc. (Coralville, IA).
RNAi design and delivery by lentiviral system FG12
The RNAi Selection Program, as described previously (Yuan et al.,
2004), was used to identify possible RNAi target sequences, which
were then scored as reported (Reynolds et al., 2004). The selected
RNAi sequences against MMP10 and HB-EGF, two well-known
pro-motility factors, and CXCL3, a less characterized gene in HK
migration, were synthesized and cloned into the lentiviral RNAi
delivery vector, FG12 (Qin et al., 2003). Transfection and virus stock
production were as described previously by us (Guan et al., 2007).
The gene transduction efficiency was analyzed with a fluorescence
microscope for a coexpressed green fluorescent protein marker gene
on the same vector. The selected RNAi sequences (sense) against the
three selected genes were as follows: for human MMP10, as
previously reported (Meyer et al., 2005); for human HB-EGF,
GAAGUUGGGCAUGACUAAU; and for human CXCL3, GUCCGU
GGUCACUGAACUG. Downregulation of the gene products was
verified by immunoblotting analyses with antibodies against
MMP-10, HB-EGF, or CXCL3.
Cell migration and DNA synthesis assays
The colloidal gold migration assay and [3H]thymidine incorporation
assay were as previously described (Li et al., 2004a; Bandyopadhyay
et al., 2006).
Patient consent for experiments was not required because French
laws consider human tissue left over from surgery as discarded
material. All the above studies received USC institutional approval
and adhered to the Declaration of Helsinki Principles. The GEO
accession number is GSE853.
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